17 Jan 2022 --- Unilever’s feverish pursuit of GlaxoSmithKline (GSK) Consumer Healthcare division has been met with multiple rejections for undervaluing the market potential of the businesses. The company’s ambition to bring GSK into the fold aligns with its unification strategy primarily focused on expanding its presence in health, beauty and hygiene.
